Type 2 diabetes, CVD, metabolic risk factors (including glucose tolerance, insulin sensitivity, dyslipidaemia, blood pressure, uric acid and inflammation) and all-cause mortality. This evidence concerns the gene INS and type 2 diabetes mellitus.